Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia

Bettina Kárai, Zsuzsanna Hevessy, Eszter Szánthó, László Csáthy, Anikó Ujfalusi, Katalin Gyurina, István Szegedi, J. Kappelmayer, C. Kiss

Research output: Article

1 Citation (Scopus)

Abstract

Previously we identified B-cell lineage leukemic lymphoblasts as a new expression site for subunit A of blood coagulation factor XIII (FXIII-A). On the basis of FXIII-A expression, various subgroups of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) can be identified. Fifty-five children with BCP-ALL were included in the study. Bone marrow samples were obtained by aspiration and the presence of FXIII-A was detected by flow cytometry. G-banding and fluorescent in situ hybridization was performed according to standard procedures. The 10-year event-free survival (EFS) and overall survival (OS) rate of FXIII-A-positive and FXIII-A-negative patients showed significant differences (EFS: 84% vs. 61%, respectively; p = 0.031; OS: 89% vs. 61%; p = 0.008). Of all the parameters examined, there was correlation only between FXIII-A expression and ‘B-other’ genetic subgroup. Further multivariate Cox regression analysis of FXIII-subtype and genetic group or ‘B-other’ subgroup identified the FXIII-A negative characteristic as an independent factor associated with poor outcome in BCP-ALL. We found an excellent correlation between long-term survival and the FXIII-A-positive phenotype of BCP lymphoblasts at presentation. The results presented seem to be convincing enough to suggest a possible role for FXIII-A expression in the prognostic grouping of childhood BCP-ALL patients.

Original languageEnglish
Pages (from-to)345-352
Number of pages8
JournalPathology and Oncology Research
Volume24
Issue number2
DOIs
Publication statusPublished - ápr. 1 2018

Fingerprint

Factor XIII
B-Lymphoid Precursor Cells
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Disease-Free Survival
Survival
Cell Lineage
Fluorescence In Situ Hybridization
Flow Cytometry
B-Lymphocytes
Survival Rate
Bone Marrow
Regression Analysis
Phenotype
factor XIII subunit A

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia. / Kárai, Bettina; Hevessy, Zsuzsanna; Szánthó, Eszter; Csáthy, László; Ujfalusi, Anikó; Gyurina, Katalin; Szegedi, István; Kappelmayer, J.; Kiss, C.

In: Pathology and Oncology Research, Vol. 24, No. 2, 01.04.2018, p. 345-352.

Research output: Article

Kárai, Bettina ; Hevessy, Zsuzsanna ; Szánthó, Eszter ; Csáthy, László ; Ujfalusi, Anikó ; Gyurina, Katalin ; Szegedi, István ; Kappelmayer, J. ; Kiss, C. / Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia. In: Pathology and Oncology Research. 2018 ; Vol. 24, No. 2. pp. 345-352.
@article{c214ef7dda744ea0ba639dc65e16cdfc,
title = "Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia",
abstract = "Previously we identified B-cell lineage leukemic lymphoblasts as a new expression site for subunit A of blood coagulation factor XIII (FXIII-A). On the basis of FXIII-A expression, various subgroups of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) can be identified. Fifty-five children with BCP-ALL were included in the study. Bone marrow samples were obtained by aspiration and the presence of FXIII-A was detected by flow cytometry. G-banding and fluorescent in situ hybridization was performed according to standard procedures. The 10-year event-free survival (EFS) and overall survival (OS) rate of FXIII-A-positive and FXIII-A-negative patients showed significant differences (EFS: 84{\%} vs. 61{\%}, respectively; p = 0.031; OS: 89{\%} vs. 61{\%}; p = 0.008). Of all the parameters examined, there was correlation only between FXIII-A expression and ‘B-other’ genetic subgroup. Further multivariate Cox regression analysis of FXIII-subtype and genetic group or ‘B-other’ subgroup identified the FXIII-A negative characteristic as an independent factor associated with poor outcome in BCP-ALL. We found an excellent correlation between long-term survival and the FXIII-A-positive phenotype of BCP lymphoblasts at presentation. The results presented seem to be convincing enough to suggest a possible role for FXIII-A expression in the prognostic grouping of childhood BCP-ALL patients.",
keywords = "Factor XIII-A, Immunophenotype, Precursor B-cell acute lymphoblastic leukemia, ‘B-other’ ALL",
author = "Bettina K{\'a}rai and Zsuzsanna Hevessy and Eszter Sz{\'a}nth{\'o} and L{\'a}szl{\'o} Cs{\'a}thy and Anik{\'o} Ujfalusi and Katalin Gyurina and Istv{\'a}n Szegedi and J. Kappelmayer and C. Kiss",
year = "2018",
month = "4",
day = "1",
doi = "10.1007/s12253-017-0236-0",
language = "English",
volume = "24",
pages = "345--352",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia

AU - Kárai, Bettina

AU - Hevessy, Zsuzsanna

AU - Szánthó, Eszter

AU - Csáthy, László

AU - Ujfalusi, Anikó

AU - Gyurina, Katalin

AU - Szegedi, István

AU - Kappelmayer, J.

AU - Kiss, C.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Previously we identified B-cell lineage leukemic lymphoblasts as a new expression site for subunit A of blood coagulation factor XIII (FXIII-A). On the basis of FXIII-A expression, various subgroups of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) can be identified. Fifty-five children with BCP-ALL were included in the study. Bone marrow samples were obtained by aspiration and the presence of FXIII-A was detected by flow cytometry. G-banding and fluorescent in situ hybridization was performed according to standard procedures. The 10-year event-free survival (EFS) and overall survival (OS) rate of FXIII-A-positive and FXIII-A-negative patients showed significant differences (EFS: 84% vs. 61%, respectively; p = 0.031; OS: 89% vs. 61%; p = 0.008). Of all the parameters examined, there was correlation only between FXIII-A expression and ‘B-other’ genetic subgroup. Further multivariate Cox regression analysis of FXIII-subtype and genetic group or ‘B-other’ subgroup identified the FXIII-A negative characteristic as an independent factor associated with poor outcome in BCP-ALL. We found an excellent correlation between long-term survival and the FXIII-A-positive phenotype of BCP lymphoblasts at presentation. The results presented seem to be convincing enough to suggest a possible role for FXIII-A expression in the prognostic grouping of childhood BCP-ALL patients.

AB - Previously we identified B-cell lineage leukemic lymphoblasts as a new expression site for subunit A of blood coagulation factor XIII (FXIII-A). On the basis of FXIII-A expression, various subgroups of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) can be identified. Fifty-five children with BCP-ALL were included in the study. Bone marrow samples were obtained by aspiration and the presence of FXIII-A was detected by flow cytometry. G-banding and fluorescent in situ hybridization was performed according to standard procedures. The 10-year event-free survival (EFS) and overall survival (OS) rate of FXIII-A-positive and FXIII-A-negative patients showed significant differences (EFS: 84% vs. 61%, respectively; p = 0.031; OS: 89% vs. 61%; p = 0.008). Of all the parameters examined, there was correlation only between FXIII-A expression and ‘B-other’ genetic subgroup. Further multivariate Cox regression analysis of FXIII-subtype and genetic group or ‘B-other’ subgroup identified the FXIII-A negative characteristic as an independent factor associated with poor outcome in BCP-ALL. We found an excellent correlation between long-term survival and the FXIII-A-positive phenotype of BCP lymphoblasts at presentation. The results presented seem to be convincing enough to suggest a possible role for FXIII-A expression in the prognostic grouping of childhood BCP-ALL patients.

KW - Factor XIII-A

KW - Immunophenotype

KW - Precursor B-cell acute lymphoblastic leukemia

KW - ‘B-other’ ALL

UR - http://www.scopus.com/inward/record.url?scp=85019612221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019612221&partnerID=8YFLogxK

U2 - 10.1007/s12253-017-0236-0

DO - 10.1007/s12253-017-0236-0

M3 - Article

VL - 24

SP - 345

EP - 352

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 2

ER -